Jump to content

Search the Community

Showing results for tags 'psma pet'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


    • Announcements, meetings and other resources
    • Primary hormone therapy
    • Secondary hormone therapy
    • Castrate Resistant Prostate Cancer
    • Metastatic
    • Very high risk
    • New agents
    • Every little bit helps
    • Radiation, diagnostic imaging, bones and other prostate cancer topics
    • Articles on other sites
    • My story
    • Any suggestions?
    • The lounge

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...

Found 3 results

  1. "Another new form of radioisotope, copper-64 (64Cu), has recently undergone Phase I clinical testing for similar uses when linked to the PSMA-617 ligand. One of the potential benefits of a 64Cu-PSMA imaging agent is that it is more stable and has a longer half-life than 68Ga. This means that this imaging agent could be made at a central facility and distributed from there to clinical PET scan centers that don’t have the radiochemistry capabilities necessary for the preparation of 68Ga-PSMA imaging agents." The New Prostate Cancer Infolink has a report on the trial carried out at two nuclear medicine centers (in Vienna, Austria, and Bad Berka, Germany).
  2. The Prostate Cancer Foundation of Australia has published a video of Professor Michael Hofman of Peter MacCallum Cancer Centre in Melbourne. The video talks about the benefits of using a new type of scan, the PSMA PET Scan, and the new possibilities for treatment that this new scan opens up.
  3. PSA since last Zoladex in Aug 2013 was .04 and since then has slowly crept up to .69 in April 2016 without any treatment. Doc wants me to have PSMA test to determine if and where cancer could be. Test is expensive but because of my military service should be covered by DVA. Is this the path I should be taking?
  • Create New...